News

SAN DIEGO — Patients with atopic dermatitis (AD) are at a significantly higher risk for nonmelanoma skin cancer (NMSC), ...
Atopic dermatitis—the most common type of eczema—can look very different on darker skin tones. As someone living with the ...
A new study conducted by researchers at National Jewish Health has found that early changes in the cheek skin barrier may ...
Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond ...
Researchers reported key differences in atopic dermatitis presentation across racial groups and steps clinicians can take to ...
Turmeric, a common spice, has been used in Eastern medicine for centuries. Studies are now examining the benefits of yellow ...
Discover a study that where results demonstrated significantly greater improvement in the ivarmacitinib groups compared to ...
Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.
LEO Pharma has reported positive topline outcomes from the randomised Phase IIb trial of the IL-22 receptor subunit alpha 1 ...